Background A proposal has recently been advanced to change the traditional definition of
nonalcoholic fatty liver disease to metabolic-associated fatty liver disease (MAFLD), to reflect …

Background Metabolic diseases are risk factors for severe Coronavirus disease (COVID-19),
which have a close relationship with metabolic dysfunction-associated fatty liver disease …

Abstract The Corona Virus Disease 2019 (COVID‐19) pandemic has attracted increasing
worldwide attention. While metabolic‐associated fatty liver disease (MAFLD) affects a …

Abstract The coronavirus disease 2019 (COVID-19) outbreak has drawn the scientific
community's attention to pre-existing metabolic conditions that could aggravate the infection …

Aim Coronavirus disease 2019 (COVID-19) is a recently encountered disease that was
declared a pandemic by WHO in 2020. Obesity and other components of the metabolic …

Background The association between metabolic-associated fatty liver disease (MAFLD) and
disease progression in patients with the coronavirus disease 2019 (COVID-19) are unclear …

Abstract The coronavirus disease 2019 (COVID-19) is caused by the severe acute
respiratory syndrome coronavirus type 2 (SARS-CoV-2). At present, the COVID-19 has been …

Background: The prevalence of metabolic dysfunction-associated fatty liver disease
(MAFLD) in coronavirus disease-2019 (COVID-19) patients and whether it affects the …

Background The novel coronavirus disease (COVID-19) emerged from China in 2019 and
rapidly spread worldwide. Patients with metabolic comorbid conditions are more susceptible …

Abstract Background Initial evidence from China suggests that most vulnerable subjects to
COVID‐19 infection suffer from pre‐existing illness, including metabolic abnormalities. The …